Bottorff M - Search Results

Year	Number of Results
1970	1
1971	1
1983	2
1984	2
1985	2
1986	2
1987	9
1988	3
1989	5
1990	4
1991	2
1992	1
1993	2
1994	2
1995	2
1996	3
1997	2
1999	3
2000	2
2001	1
2002	2
2003	2
2004	4
2006	2
2007	1
2010	1
2011	2
2012	3
2013	5
2014	11
2015	11
2016	4
2017	2
2018	2
2020	5
2021	2
2022	2
2023	2
2024	0

1

Ranibizumab and bevacizumab for neovascular age-related macular degeneration.

CATT Research Group; Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ. CATT Research Group, et al. N Engl J Med. 2011 May 19;364(20):1897-908. doi: 10.1056/NEJMoa1102673. Epub 2011 Apr 28. N Engl J Med. 2011. PMID: 21526923 Free PMC article. Clinical Trial.

2

Amniography.

Bottorff MK, Fish SA. Bottorff MK, et al. South Med J. 1971 Oct;64(10):1203-6. doi: 10.1097/00007611-197110000-00009. South Med J. 1971. PMID: 5097793 No abstract available.

3

Role of the pharmacist.

Bottorff M. Bottorff M. Pharmacotherapy. 2006 Dec;26(12 Pt 2):227S-232S. doi: 10.1592/phco.26.12part2.227S. Pharmacotherapy. 2006. PMID: 17125450

4

Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review.

Hilleman DE, Wiggins BS, Bottorff MB. Hilleman DE, et al. Among authors: bottorff mb. Adv Ther. 2020 Feb;37(2):656-670. doi: 10.1007/s12325-019-01211-1. Epub 2020 Jan 9. Adv Ther. 2020. PMID: 31919792 Free PMC article. Review.

5

Treating dyslipidemic patients with lipid-modifying and combination therapies.

Worz CR, Bottorff M. Worz CR, et al. Among authors: bottorff m. Pharmacotherapy. 2003 May;23(5):625-37. doi: 10.1592/phco.23.5.625.32204. Pharmacotherapy. 2003. PMID: 12741437 Review.

6

Statin safety and drug interactions: clinical implications.

Bottorff MB. Bottorff MB. Am J Cardiol. 2006 Apr 17;97(8A):27C-31C. doi: 10.1016/j.amjcard.2005.12.007. Epub 2006 Jan 25. Am J Cardiol. 2006. PMID: 16581325 Review.

7

Calcium channel blockers as inhibitors of drug metabolism.

Hunt BA, Self TH, Lalonde RL, Bottorff MB. Hunt BA, et al. Among authors: bottorff mb. Chest. 1989 Aug;96(2):393-9. doi: 10.1378/chest.96.2.393. Chest. 1989. PMID: 2568899 Review. No abstract available.

8

Commentary: Should Pharmacogenomic Evidence Be Considered in Clinical Decision Making? Focus on Select Cardiovascular Drugs.

Bottorff MB, Bright DR, Kisor DF. Bottorff MB, et al. Pharmacotherapy. 2017 Sep;37(9):1005-1013. doi: 10.1002/phar.1979. Epub 2017 Aug 15. Pharmacotherapy. 2017. PMID: 28654154 Review.

9

Management of heart failure. I. Pharmacologic treatment.

Baker DW, Konstam MA, Bottorff M, Pitt B. Baker DW, et al. Among authors: bottorff m. JAMA. 1994 Nov 2;272(17):1361-6. JAMA. 1994. PMID: 7933398 Review.

10

'Fire and forget?' - pharmacological considerations in coronary care.

Bottorff M. Bottorff M. Atherosclerosis. 1999 Sep 9;147 Suppl 1:S23-30. doi: 10.1016/s0021-9150(99)00252-x. Atherosclerosis. 1999. PMID: 10575059 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Results by year